These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2569458)

  • 1. Buspirone revisited.
    Lydiard RB
    J Clin Psychiatry; 1989 Aug; 50(8):308. PubMed ID: 2569458
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent movement disorders induced by buspirone.
    LeWitt PA; Walters A; Hening W; McHale D
    Mov Disord; 1993 Jul; 8(3):331-4. PubMed ID: 8101969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tardive dyskinesia: problems of pathogenesis, treatment and prevention].
    Olajossy M
    Psychiatr Pol; 1980; 14(6):621-5. PubMed ID: 6112766
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral dyskinesia associated with buspirone use in an elderly woman.
    Strauss A
    J Clin Psychiatry; 1988 Aug; 49(8):322-3. PubMed ID: 3045105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of buspirone in seven schizophrenic subjects.
    Brody D; Adler LA; Kim T; Angrist B; Rotrosen J
    J Clin Psychopharmacol; 1990 Feb; 10(1):68-9. PubMed ID: 1968473
    [No Abstract]   [Full Text] [Related]  

  • 6. Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients.
    Chouinard G; Annable L; Ross-Chouinard A
    Psychopharmacol Bull; 1986; 22(3):891-6. PubMed ID: 2879310
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a presynaptic tardive dyskinesia?
    Bowers MB; Glazer WM
    J Clin Psychopharmacol; 1987 Feb; 7(1):57-9. PubMed ID: 2880877
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
    Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
    Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
    [No Abstract]   [Full Text] [Related]  

  • 9. Dyskinesia induced by long-term treatment with antipsychotic drugs: involvement of pre- and postsynaptic dopaminergic mechanisms.
    Engel J; Liljequist S; Goldstein M
    Adv Biochem Psychopharmacol; 1980; 23():387-95. PubMed ID: 6104913
    [No Abstract]   [Full Text] [Related]  

  • 10. Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesia.
    Diamond BI; Borison RL
    Psychopharmacol Bull; 1986; 22(3):900-5. PubMed ID: 2879312
    [No Abstract]   [Full Text] [Related]  

  • 11. Buspirone and dyskinesia.
    Simpson GM; Singh H
    J Clin Psychiatry; 1988 Dec; 49(12):503. PubMed ID: 3198582
    [No Abstract]   [Full Text] [Related]  

  • 12. Buspirone in the treatment of tardive dyskinesia.
    Moss LE; Neppe VM; Drevets WC
    J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Movement disorders and new azapirone anxiolytic drugs.
    Jann MW; Froemming JH; Borison RL
    J Am Board Fam Pract; 1990; 3(2):111-9. PubMed ID: 2185606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tardive dyskinesia].
    Kato M; Watanabe K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):183-7. PubMed ID: 12876961
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tardive dyskinesia].
    Sabbatini F; Gentile S; De Mattei M; Pinessi L; Rainero I
    Minerva Med; 1985 Apr; 76(16):797-802. PubMed ID: 2860619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tardive dyskinesias. Epidemiology and physiopathology].
    Gerlach J
    Ugeskr Laeger; 1987 Jun; 149(25):1678-81. PubMed ID: 2885954
    [No Abstract]   [Full Text] [Related]  

  • 17. A therapeutic approach to tardive dyskinesia.
    Fahn S
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and pathophysiology of tardive dyskinesias.
    Klawans HL; Tanner CM; Goetz CG
    Adv Neurol; 1988; 49():185-97. PubMed ID: 2894124
    [No Abstract]   [Full Text] [Related]  

  • 19. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis.
    Csernansky JG; Vinogradov S; Prosser E; Kaplan J; Berger PA; Hollister LE
    Psychopharmacol Bull; 1986; 22(3):897-9. PubMed ID: 2879311
    [No Abstract]   [Full Text] [Related]  

  • 20. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
    Rondot P; Bathien N
    Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.